• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Recent Advances in the Study of 3-Chloro-4-Fluorobenzene-1-Carboximidamide (CAS: 504404-34-6) in Chemical Biology and Pharmaceutical Research

The compound 3-chloro-4-fluorobenzene-1-carboximidamide (CAS: 504404-34-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This molecule, characterized by its unique structural features, has been explored for its potential as a key intermediate in the synthesis of various bioactive compounds. Recent studies have highlighted its role in the development of novel therapeutic agents, particularly in the areas of antimicrobial and anticancer research.

One of the most notable advancements in the study of 3-chloro-4-fluorobenzene-1-carboximidamide is its incorporation into the design of small-molecule inhibitors targeting specific enzymes and receptors. For instance, researchers have utilized this compound as a scaffold to develop inhibitors of protein kinases, which play a critical role in cell signaling pathways associated with cancer progression. The chloro and fluoro substituents on the benzene ring have been shown to enhance the binding affinity and selectivity of these inhibitors, making them promising candidates for further preclinical evaluation.

In addition to its applications in oncology, 3-chloro-4-fluorobenzene-1-carboximidamide has also been investigated for its antimicrobial properties. Recent studies have demonstrated its efficacy against a range of bacterial and fungal pathogens, including drug-resistant strains. The mechanism of action appears to involve disruption of microbial cell wall synthesis, although further research is needed to fully elucidate the underlying pathways. These findings underscore the potential of this compound as a lead structure for the development of new antimicrobial agents.

The synthesis and optimization of 3-chloro-4-fluorobenzene-1-carboximidamide derivatives have also been a focus of recent research. Advances in synthetic chemistry have enabled the efficient production of various analogs with improved pharmacokinetic properties. For example, modifications to the carboximidamide moiety have been shown to enhance the compound's solubility and bioavailability, addressing some of the challenges associated with its clinical translation. These developments highlight the importance of structural optimization in maximizing the therapeutic potential of this compound.

Despite these promising findings, several challenges remain in the development of 3-chloro-4-fluorobenzene-1-carboximidamide-based therapeutics. Issues such as off-target effects, toxicity, and metabolic stability need to be carefully addressed in future studies. Nevertheless, the growing body of research on this compound underscores its significance in the field of chemical biology and pharmaceutical research. Continued exploration of its applications and mechanisms of action is expected to yield valuable insights and contribute to the discovery of new therapeutic agents.

In conclusion, 3-chloro-4-fluorobenzene-1-carboximidamide (CAS: 504404-34-6) represents a promising scaffold for the development of novel bioactive compounds. Its diverse applications in drug discovery, coupled with recent advancements in synthetic and medicinal chemistry, position it as a valuable tool for researchers in the field. Future studies should focus on addressing the remaining challenges and further elucidating its potential in various therapeutic areas.

• 582306-90-9(2-Chloro-4-fluoro-benzamidine)
• 1187927-09-8(4-Chloro-2-fluoro-benzamidine Hydrochloride)
• 72235-56-4(1-(3-chloro-4-fluorophenyl)methanamine)
• 477904-79-3(BENZENECARBOXIMIDAMIDE, 4-FLUORO-, HYDROCHLORIDE)
• 1171478-64-0(2-Chloro-4-fluoro-benzamidine HCl)
• 456-14-4(4-Fluorobenzamidine Hydrochloride)
• 1187929-52-7(5-Chloro-2-fluoro-benzamidine hydrochloride)
• 1187929-32-3(4-chloro-2-fluorobenzene-1-carboximidamide)
• 477844-52-3(3-chloro-4-fluoro-benzamidine hydrochloride)
• 674793-32-9(5-chloro-2-fluorobenzamidine hydrochloride)